Dr. Radin has served as the Medical Director and as a Principal Investigator for Stamford Therapeutics Consortium since 2005. For more than twenty five years, he has grown and successfully managed his own private practice in Internal Medicine in Stamford, CT. During that time, he has also had extensive experience with CRO’s and sponsors on a variety of clinical trials in multiple diagnostic areas. While specializing in studies focused on internal medicine, he has also overseen research in hypertension, heart failure, vaccine and immunology, rheumatology, women’s health, infectious disease, metabolism and obesity. A board-certified internist, Dr. Radin plays an integral leadership role at STC, evaluating the real-world feasibility of STC’s protocols, and providing comprehensive guidance and leadership for the clinical team.

Dr. Radin earned a BS in chemistry from the Massachusetts Institute of Technology and did post graduate work at Columbia University before being awarded his MD by New York Medical College in 1990. Dr. Radin is GCP, C-SSRS and GRAPPA certified, and has extensive training in multiple EDC systems.